Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Anhui Cancer Hospital, Hefei, Anhui, China
Contact: Study coordinator (Shuanghu Yuan, PhD) · yuanshuanghu@sina.com · 0551-62894008

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Extensive Stage Lung Small Cell Cancer · Extensive-Stage Small-Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Changsha, China · Jinan, China

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Extensive-Stage Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Lung Cancer · Extensive-stage Small-cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chengdu, China

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Chengdu, China